ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- Wall St set for higher open as AI stocks rise, oil slides
ResMed (RMD) Reports In-Line Q1 EPS
October 27, 2022 4:16 PM EDTResMed (NYSE: RMD) reported Q1 EPS of $1.51, in-line with the analyst estimate of $1.51. Revenue for the quarter came in at $950.3 million versus the consensus estimate of $947.96 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
... More